IL27 and neoplasm: Although the molecular mechanisms that may cause treatment failure remain to be investigated, the emergence of treatment resistance and resumption of tumor progression could be limited by combining IL30 suppression with immunotherapy or other personalized treatments, as observed in the combined treatment protocols that have been successfully used for the management of different types of advanced stage cancer58,59.